RVMD logo

Revolution Medicines (RVMD)

Profile

Full Name

Revolution Medicines, Inc.

Ticker Symbol

RVMD

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 13, 2020

Indexes

Not included

Website

http://www.revmed.com

Employees

534

Key Details

Price

$35.72(+6.09%)

Market cap

$6.64B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.58(+7.25% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$35.72
RVMD price is $35.72

30-Day Relative Volume

1.03
RVMD 30-day relative volume is 1.03

Price Performance

Price Most recent change

+6.09%
RVMD price was up +6.09% on Apr 11, 2025

Price YTD change

-18.34%
RVMD price is down -18.34% since January 1st

Price 1-year change

-4.52%
RVMD price is down -4.52% year-on-year

Price 3-year change

+51.68%
RVMD price is up +51.68% over the past 3 years

Price Range

Price All-time high

$62.40
RVMD price is currently -42.76% below its historical high of $62.40

Price 3-year low

$14.08
RVMD price is currently +153.69% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$6.64B
RVMD market capitalization is $6.64 billion

Market cap 3-year change

+279.9%
RVMD market capitalization is up +279.9% over the past 3 years

Market cap All-time high

$10.93B
RVMD market capitalization is currently -39.27% below its historical high of $10.93 billion

Market cap sector rank

90.71%
RVMD market capitalization is higher than 90.71% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+12.73%
RVMD shares outstanding is up +12.73% year-on-year

Shares Outstanding 3-Year Change

+150.46%
RVMD shares outstanding is up +150.46% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.11
RVMD beta is 1.11

200-day SMA

$44.34
RVMD price is currently -19.43% below its 200-day simple moving average

50-day SMA

$38.82
RVMD price is currently -7.99% below its 50-day simple moving average

RSI

48.40
RVMD 14-day relative strength index is 48.40

Volume

1.03
RVMD 30-day relative volume is 1.03

ATR

$2.23
RVMD average true range is $2.23

10-day Historical Volatility

95.66%
RVMD 10-day historical volatility is 95.66%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
RVMD annual revenue value is unknown

Revenue Analysts estimate

$1.64M
RVMD annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
RVMD annual revenue 1-year change is unknown

Revenue Sector rank

-
RVMD annual revenue is unknown

EPS

EPS

-$3.58
RVMD annual earnings per share is -$3.58

EPS Analysts estimate

-$4.48
RVMD annual earnings per share is currently -20.02% lower than the consensus analysts' forecast

EPS 1-year change

+7.25%
RVMD annual earnings per share is up +7.25% year-on-year

EPS Sector rank

25.02%
RVMD annual earnings per share is higher than 25.02% of companies in Healthcare sector

Profit

Gross profit

-
RVMD annual gross profit value is unknown

Gross margin

-
RVMD annual gross profit margin value is unknown

Operating profit

-$689.52M
RVMD annual operating income is -$689.52 million

Operating margin

-
RVMD annual operating profit margin value is unknown

Net income

-$600.09M
RVMD annual net profit is -$600.09 million

Net margin

-
RVMD annual net profit margin value is unknown

Expenses

Total expenses

$689.52M
RVMD annual total expenses is $689.52 million

Operating expenses

$689.52M
RVMD annual total operating expenses is $689.52 million

Cost of goods sold

-
RVMD annual cost of goods sold value is unknown

Selling, general & administrative expenses

$97.30M
RVMD annual SGA is $97.30 million

Depreciation and amortization

$11.82M
RVMD annual depreciation & amortization is $11.82 million

Interest expense

-
RVMD annual interest expense value is unknown

Income tax

-$753.00K
RVMD annual income tax is -$753.00 thousand

EBIT & EBITDA

EBIT

-$689.52M
RVMD annual earnings before interest & taxes is -$689.52 million

EBITDA

-$677.70M
RVMD annual EBITDA is -$677.70 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$2.56B
RVMD annual total assets is $2.56 billion

Non current assets

$230.67M
RVMD annual long term assets is $230.67 million

Current assets

$2.33B
RVMD annual total current assets is $2.33 billion

Cash and cash equivalents

$543.06M
RVMD annual cash & cash equivalents is $543.06 million

Accounts receivable

$0.00
RVMD annual accounts receivable is $0.00

Inventory

-
RVMD annual inventory value is unknown

Liabilities

Total liabilities

$293.10M
RVMD annual total liabilities is $293.10 million

Long term liabilities

$129.18M
RVMD annual total long term liabilities is $129.18 million

Current liabilities

$163.91M
RVMD annual total current liabilities is $163.91 million

Accounts payable

$54.43M
RVMD annual accounts payable is $54.43 million

Debt

Total debt

$135.84M
RVMD annual total debt is $135.84 million

Total debt 1-year change

+54.47%
RVMD annual total debt is up +54.47% year-on-year

Long term debt

$122.97M
RVMD annual long term debt is $122.97 million

Short term debt

$12.87M
RVMD annual short term debt is $12.87 million

Equity & Capital

Shareholders equity

$2.27B
RVMD annual stockholders equity is $2.27 billion

Book value

$2.27B
RVMD annual book value is $2.27 billion

Retained earnings

-$1.74B
RVMD annual retained earnings is -$1.74 billion

Working capital

$2.16B
RVMD annual working capital is $2.16 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$557.44M
RVMD annual cash flow from operations is -$557.44 million

Cash from operations 1-year change

-59.01%
RVMD annual cash flow from operations is down -59.01% year-on-year

Cash from investing

-$554.39M
RVMD annual cash flow from investing activities is -$554.39 million

Cash from investing 1-year change

-61.82%
RVMD annual cash flow from investing activities is down -61.82% year-on-year

Cash from financing

$959.41M
RVMD annual cash flow from financing activities is $959.41 million

Cash from financing 1-year change

-21.95%
RVMD annual cash flow from financing activities is down -21.95% year-on-year

CAPEX

CAPEX

-
RVMD annual capital expenditures value is unknown

CAPEX 1-year change

-
RVMD annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$567.74M
RVMD annual free cash flow is -$567.74 million

Free cash flow 1-year change

-58.45%
RVMD annual free cash flow is down -58.45% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
RVMD annual gross profit margin value is unknown

Operating margin

-
RVMD annual operating profit margin value is unknown

Net margin

-
RVMD annual net profit margin value is unknown

ROA & ROE

ROA

-23.46%
RVMD annual return on assets is -23.46%

ROE

-26.49%
RVMD annual return on equity is -26.49%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
RVMD price to earnings ratio value is unknown

PE ratio Sector rank

-
RVMD price to earnings ratio is unknown

PB Ratio

PB ratio

2.93
RVMD price to book ratio is 2.93

PB ratio Sector rank

72.2%
RVMD price to book ratio is higher than 72.2% of companies in Healthcare sector

PS Ratio

PS ratio

-
RVMD price to sales ratio value is unknown

PS ratio Sector rank

-
RVMD price to sales ratio is unknown

Enterprise value

Enterprise value

$6.23B
RVMD enterprise value is $6.23 billion

Enterprise value Sector rank

89.61%
RVMD enterprise value is higher than 89.61% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-9.20
RVMD EV/EBITDA is -9.20

EV/EBITDA Sector rank

11.63%
RVMD EV/EBITDA is higher than 11.63% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

14.20
RVMD annual current ratio is 14.20

Quick ratio

-
RVMD annual quick ratio value is unknown

Leverage

Debt to equity

0.06
RVMD annual debt to equity ratio is 0.06

Interest coverage ratio

-
RVMD annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
RVMD piotroski f-score value is unknown

Altman Z-Score

-
RVMD altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 8, 25 Needham
Buy
Apr 1, 25 Stifel
Buy
Mar 3, 25 HC Wainwright & Co.
Buy
Feb 27, 25 Stifel
Buy
Feb 27, 25 Needham
Buy
Jan 8, 25 UBS
Buy
Dec 6, 24 Wedbush
Outperform
Dec 6, 24 Needham
Buy
Dec 4, 24 HC Wainwright & Co.
Buy
Dec 3, 24 Needham
Buy

Institutional Ownership

Similar stocks

BBIO logo
BridgeBio Pharma (BBIO)
WAY logo
Waystar Holding (WAY)
BIO logo
Bio-Rad Laboratories (BIO)
RGEN logo
Repligen (RGEN)
LNTH logo
Lantheus Holdings (LNTH)
MDGL logo
Madrigal Pharmaceuticals (MDGL)
ROIV logo
Roivant Sciences (ROIV)
HQY logo
HealthEquity (HQY)
JAZZ logo
Jazz Pharmaceuticals (JAZZ)
  • What is the ticker symbol for Revolution Medicines?
  • Does Revolution Medicines pay dividends?
  • What sector is Revolution Medicines in?
  • What industry is Revolution Medicines in?
  • What country is Revolution Medicines based in?
  • When did Revolution Medicines go public?
  • Is Revolution Medicines in the S&P 500?
  • Is Revolution Medicines in the NASDAQ 100?
  • Is Revolution Medicines in the Dow Jones?
  • When was Revolution Medicines's last earnings report?
  • When does Revolution Medicines report earnings?
  • Should I buy Revolution Medicines stock now?

What is the ticker symbol for Revolution Medicines?

The ticker symbol for Revolution Medicines is NASDAQ:RVMD

Does Revolution Medicines pay dividends?

No, Revolution Medicines does not pay dividends

What sector is Revolution Medicines in?

Revolution Medicines is in the Healthcare sector

What industry is Revolution Medicines in?

Revolution Medicines is in the Biotechnology industry

What country is Revolution Medicines based in?

Revolution Medicines is headquartered in United States

When did Revolution Medicines go public?

Revolution Medicines's initial public offering (IPO) was on February 13, 2020

Is Revolution Medicines in the S&P 500?

No, Revolution Medicines is not included in the S&P 500 index

Is Revolution Medicines in the NASDAQ 100?

No, Revolution Medicines is not included in the NASDAQ 100 index

Is Revolution Medicines in the Dow Jones?

No, Revolution Medicines is not included in the Dow Jones index

When was Revolution Medicines's last earnings report?

Revolution Medicines's most recent earnings report was on Feb 26, 2025

When does Revolution Medicines report earnings?

The next expected earnings date for Revolution Medicines is May 8, 2025

Should I buy Revolution Medicines stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page